Objectives: To correlate the ultrasound appearance of highly vascularised uterine myomas to the histopathological diagnosis. Methods: This retrospective study included patients presenting with an ultrasound diagnosis of uterine myoma characterised by a circumferential and intralesional vascular pattern with a colour score assessment of 3 or 4, according to the Morphological Uterus Sonographic Assessment (MUSA). All the patients underwent myomectomy or hysterectomy after the ultrasound examination. The ultrasound appearance of the myomas was analysed and described using the terms and definitions of the MUSA paper. The echogenicity of each myoma, the presence of cystic areas and the total myoma volume were recorded. The ultrasound characteristics were compared with the histological diagnosis. Results: 52 patients were included in this study. Mean patient age was 42.5 years, 45 (86%) were in premenopause, 26 (50%) showed symptoms (pelvic pain, menorrhagia). At histological examination 25 (48%) myomas were compatible with a diagnosis of atypical leiomyoma (76% (19) hypercellular leiomyoma, 16% (4) myxoid leiomyoma, 8% (2) apoplectic leiomyoma). 25 (48%) were typical leiomyomas and 2 (4%) were adenomyomas. Cystic areas within the lesion were found in 32% (8/25) of atypical leiomyomas and in 16% (4/25) of typical leiomyomas. Conclusions: Ultrasound features such as circumferential and intralesional vascularity with a colour score of 3 or 4 and the presence of cystic areas may be predictive of atypical leiomyomas. Such features may be used to differentiate typical uterine myomas from the atypical variants in a pre-operative setting and to identify patients that may benefit from a conservative medical treatment rather than a radiological treatment.
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Objectives: To compare the endometrial thickness by 2D-transvaginal sonography (2D-TVS) and 3D-TVS by Multiplanar Display and Volume Contrast Imaging (VCI) analysis. Methods: Patients scheduled for TVS were consecutively recruited. All procedures were performed with the GE Voluson E8 unit, using a wide-band 3-9 MHz transducer. Compound Resolution Imaging (CRI) and Speckle Reduction Imaging (SRI) technologies were used to optimise image before volume acquisition by enhancing contrast resolution and reducing artefacts and speckle. Endometrial thickness was measured on the sagittal plane, with a proper high quality zoomed image, at 2D and at 3D-TVS, by using multiplanar display and VCI analysis by 2mm slices of the acquired volume to obtain a correct orthogonal plane in the three axis. For each patients, three different measurements were obtained and the mean thickness was considered for data analysis. All procedures were performed by the same senior operator. Demographic, medical and sonographic data were recorded. Results: 425 patients were enrolled. Median (IR) age was 49 (39-58) years. 253 women were pre-menopausal and 172 post-menopausal. Median (IR) endometrial thickness in premenopausal women at 2D-and 3D-TVS was 6.6 (4.4-9.5) mm and 6.7 (4.2-9.7) mm, respectively. Median (IR) endometrial thickness in post-menopausal woman at 2D-and 3D-TVS was 2.2 (1.5-4.5) mm and 2.2 (1.4-4.6) mm, respectively. Neither in pre-menopausal nor in post-menopausal patients endometrial thickness was significantly different at 2D-and 3D-TVS. Similarly, when focusing on selected difficult cases, i.e. because of axial position and/or endometriosis or previous surgery-related rotation of the uterus, no significant data were found. Conclusions: The measurement of endometrial thickness by 2D-and 3D-TVS in pre-and post-menopausal was not significantly different. Multiplanar VCI analysis, by 2mm slices, permitted to obtain a better defined and properly measured endometrial thickness, correctly oriented on the three orthogonal planes. Results: 1646 postmenopausal women aged 55-96 (mean 64.5 ±17.4) and their mean BMI was 31.5. The pathology breakdown showed: AE (40%), EE (16.6%) and the cancer/hyperplasia rate was 11.2%. EE condition persisted with increased age: 8.1% of women aged 75-84 had EE. Mean surveillance time was 11.5 +/-2.4 years (8.0 to 17.8 years). Women with EE were significantly younger than women with AE (61.3 vs 64.9 p<0.001). EE was associated with a significantly higher BMI (33.6 versus 30.7 AE p<0.001) and a 1.64-fold higher risk of obesity (BMI >30), p= 0.0024. On ultrasound women with EE had insignificant increase in fibroids (30.3%% vs 20.9% p=0.051) and endometrial thickness (8.2 vs 8.1mm p=0.6).
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On long term follow-up, EE was associated with a significant increase polyp formation (11.7% vs 7.2% p=0.026), all gynecologic cancers (11.3% vs 4.2% p=0.03) and future surgical intervention (27.0% vs 15.9% p=0.035). Women with EE had 3.1-fold higher risk of developing endometrial cancer or hyperplasia (p=0.002). Conclusions: In our patient population, 16.6% of women with PMB had EE.
EE is associated with increased BMI. In the absence of ovarian activity, the source of estrogen is probably peripheral conversion of androgens in the adipose tissue.
On long term, EE is associated with increase in polyp formation, endometrial cancer/hyperplasia and risk of future surgical intervention. Research is needed to evaluate if medical intervention can reduce these risks.
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Combined treatment with the levonorgestrel-releasing intrauterine device and ulipristal acetate in patients with uterine adenomyosis 
